ORUKA THERAPEUTICS INC (ORKA) Stock Income Statement
NASDAQ:ORKA • US6876041087
Current stock price
53.31 USD
+2.88 (+5.71%)
At close:
53 USD
-0.31 (-0.58%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 122.05M | 88.12M | 7.30M | 10.60M | 19.34M | |||
| Research and Development | 100.64M | 75.06M | 1.01M | 4.75M | 13.83M | |||
| Selling, General, and Administrative Expenses | 21.41M | 13.06M | 6.28M | 5.85M | 5.50M | |||
| Operating Income | -122.05M | -88.12M | -7.30M | -10.60M | -19.34M | |||
| Interest Income/Expense | 16.63M | 4.39M | 1.96M | 675.00K | 13.00K | |||
| Other Income/Expense | -12.00K | 4.00K | 0.00 | -5.00K | N/A | |||
| Income Before Taxes | -105.43M | -83.72M | -5.34M | -9.93M | -19.32M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -105.43M | -83.72M | -5.34M | -9.93M | -19.32M | |||
| EBITDA | -121.97M | -88.10M | -7.28M | -10.58M | -19.32M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.31 | -4.99 | -4.44 | -8.27 | -16.68 | |||
| Non GAAP EPS | -1.86 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD